HCPLive Network
  • CDC Chief Says Ebola Outbreak is Worse than Feared
  • Chronic Pain Peer Exchange Video Series
  • Family Practice Recertification
  • Internal Medicine World Report
  • Multiple Sclerosis Peer Exchange Video Series
  • Cardiology Review
  • Physician’s Money Digest
  • Surgical Rounds
Latest Specialty Headlines
Healthcare workers in poor nations often do not have enough protective gear to keep them safe from being infected with blood-borne viruses such as Ebola and HIV, according to a study published online Aug. 8 in Tropical Medicine & International Health.
For actinic keratoses, photodynamic therapy is associated with improved response compared with cryotherapy, according to a meta-analysis published online Aug. 27 in JAMA Dermatology.
Progress has been made toward widespread adoption of electronic health records, although there are still barriers to adoption of advanced use of EHRs, according to a report published by the Robert Wood Johnson Foundation.
By Adam Hochron
For patients with hypertension, finding the right course of treatment can be critically important especially when other health factors are taken into consideration.
By Rachel Lutz
The risks of marijuana are greatest for teen users, according to an analysis of current data from the National Institute on Drug Abuse (NIDA) published June 5, 2014 in The New England Journal of Medicine.
By Jacquelyn Gray
The International Antiviral Society–USA Panel has released its 2014 report, which provided clinical recommendations to stop HIV transmission.
By Laura Joszt
Although previous research has found probiotics can prevent antibiotic-associated diarrhea (AAD) and Clostridium difficile diarrhea (CDD), a study from researchers in the United Kingdom and Germany reported contradicting results.
By Gale Scott
Even though the active ingredient in marijuana can be associated with memory impairment, it may slow or halt Alzheimer’s disease.
By Rachel Lutz
Peripheral neuropathy was found in a third of HIV patients in a recent study of 58 men with a median age of 36 years.
By Rachel Lutz
Men who are socially well-integrated show more than a 2-fold reduced risk of suicide, according to a longitudinal study published in the Annals of Internal Medicine.
Email Signup
Breaking News
GlaxoSmithKline's Arnuity approved for patients over the age of 12 as part of treatment options
Researchers from the National Institute of Allergy and Infectious Diseases and GlaxoSmithKline will soon launch phase I clinical trials of experimental Ebola vaccines.
Physician's Money Digest
If there is one lesson investors learn, it should be to avoid being bearish for too long. Otherwise, you miss out on some incredible investment runs on Wall Street.
One accountable care organization saved $8.5 million and received a check from Medicare for $4.2 million after 17 months. Suddenly, they had physicians clamoring to join.
Product News
The European Commission (EU) has granted Bristol-Myers Squibb’s Daklinza (daclatasvir) approval for an all-oral drug regimen for the treatment of four genotypes of chronic hepatitis C infection.
An investigational drug that researchers hope will reverse nerve damage in patients with multiple sclerosis (MS) has been found to be safe and well tolerated in early trials. The big question is whether it will work, researchers said.
The US Food and Drug Administration announced it will give priority review status to Amgen’s application to market ivabradine as a treatment for chronic heart failure.
Clinicians who treat patients suffering with osteoarthritis pain have a new low-dose nonsteroidal anti-inflammatory drug (NSAID) option at their disposal. Zorvolex (diclofenac) was developed to meet prevailing FDA recommendations regarding NSAID dosing and treatment duration.
One-pill regiment includes abacavir, dolutegravir and lamivudine.